Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats

Neuropsychopharmacology

Volumn 19, Issue 5, 1998, Pages 406-416

  Schulteis, Gery ^a,b   Stinus, Luis ^c   Risbrough, Victoria B ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b University of California   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Clonidine; Conditioning; Naloxone; Opiate dependence; Opiate withdrawal

Indexed keywords

CLONIDINE; MORPHINE; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; LOCOMOTION; MALE; MORPHINE ADDICTION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-AGONISTS; ANALGESICS, OPIOID; ANIMALS; CLONIDINE; CONDITIONING, OPERANT; MALE; MORPHINE; NALOXONE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032210705     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00036-0     Document Type: Article

References (41)

1. Baldwin H.R., Koob G.F. Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology. 8:1993;15-21.
2. Beninger R.J., Herz R.S. Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning. Life Sic. 38:1986;1425-1431.
3. Britton K.T., Svensson T., Schwartz J., Bloom F.E., Koob G. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34:1984;133-139.
4. 2-adrenoceptors outside the locus coeruleus. Eur J Pharmacol. 238:1993;201-207.
5. Charney D.S., Sternberg D.E., Kleber H.D., Heninger M.D., Redmond D.E. Jr. The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms Arch Gen Psychiat. 38:1981;1273-1277.
6. Childress A.R., Ehrman R., McLellan A.T., MacRae J., Natale M., O'Brien C.P. Can induced moods trigger drug-related response in opiate abuse patients? J Subst Abuse Treat. 11:1994;17-23.
7. 2-adrenoceptor agonists in the expression of morphine-withdrawal in rats. Naunyn-Schmiedeberg's Arch Pharmacol. 345:1992;553-557.
8. Cuthill J.D., Beroniade M.D., Salvatori V.A., Viguié F. Evaluation of clonidine suppression of opiate withdrawal reactions. A multidisciplinary approach Can J Psychiat. 35:1990;377-382.
9. Dawe S., Gray J.A. Craving and drug reward. A comparison of methadone and clonidine in detoxifying opiate addicts Drug Alcohol Depend. 39:1995;207-212.
10. Gold L.H., Stinus L., Inturrisi C.E., Koob G.F. Prolonged tolerance, dependence, and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol. 253:1994;45-51.
11. Gold M.S., Redmond D.E. Jr., Kleber H.D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 2:1978;599-602.
12. Hand T.H., Koob G.F., Stinus L., Le Moal M. Aversive properties of opioid receptor blockade. Evidence for exclusively central mediation in naive and morphine-dependent rats Brain Res. 474:1988;364-368.
13. Horvitz J.C., Ettenberg A. Conditioned incentive properties of a food-paired conditioned stimulus remain intact during dopamine receptor blockade. Behav Neurosci. 105:1991;536-541.
14. Janiri L., Mannelli P., Persico A.M., Serretti A., Tempesta E. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine, and buprenorphine. Drug Alcohol Depend. 36:1994;139-145.
15. Jaffe JH (1990): Drug addiction and drug abuse. In Goodman-Gilman A, Rall TW, Nies AS, Taylor P (eds), The Pharmacological Basis of Therapeutics, New York, Pergamon Press, pp 522-573.
16. Jasinski D.R., Johnson R.E., Kocher T.R. Clonidine in morphine withdrawal. Differential effects on signs and symptoms Arch Gen Psychiat. 42:1985;1063-1066.
17. Kahn A., Mumford J.P., Rogers G.A., Beckford H. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. Drug Alcohol Depend. 44:1997;57-61.
18. Kantak K.M., Miczek K.A. Social, motor, and autonomic signs of morphine withdrawal. Differential sensitivities to catecholaminergic drugs in mice Psychopharmacology. 96:1988;468-476.
19. Kasvikis Y., Bradley Gossop M., Griffits P., Marks I. Clonidine versus long- and short-methadone-aided withdrawal from opiates. An uncontrolled comparison Int J Addict. 25:1990;1169-1174.
20. Katz J.L. Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology. 88:1986;392-397.
21. Kelsey J.E., Aranow J.S., Matthews R.T. Context-specific morphine withdrawal in rats. Duration and effects of clonidine Behav Neurosci. 104:1990;704-710.
22. Koob G.F., Wall T.L., Bloom F.E. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology. 98:1989;530-534.
23. Kosten T.A. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol. 254:1994;59-63.
24. Maldonado R., Stinus L., Koob G.F. Molecular Mechanisms of Opiate Withdrawal. 1996;Springer, New York.
25. Martinez JL Jr, Schulteis G, Weinberger SB (1991): How to increase and decrease the strength of memory traces: The effects of drugs and hormones. In Martinez JL Jr, Kesner RP (eds), Learning and Memory: A Biological View, New York, Academic Press, pp 149-198.
26. McCleary P.E., Leander J.D. Clonidine analgesia and suppression of operant responding. Dissociation of mechanism Eur J Pharmacol. 69:1981;63-69.
27. McGaugh JL (1992): Affect, neuromodulatory systems, and memory storage. In Christianson S-A (ed), The Handbook of Emotion and Memory: Research and Theory, Hillsdale, NJ, Lawrence Erlbaum Associates, pp 245-268.
28. Nader K., van der Kooy D. Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats. Behav Neurosci. 110:1996;389-400.
29. O'Brien C.P., Testa T., O'Brien T.J., Greenstein R. Conditioning in human opiate addicts. Pav J Biol Sci. 11:1976;195-203.
30. O'Brien C.P., Childress A.R., McLellan A.T., Ehrman R. Developing treatments that address classical conditioning. NIDA Res Monogr. 135:1993;71-91.
31. Ramsay D.S., Woods S.J. Biological consequences of drug administration. Implications for acute and chronic tolerance Psychol Rev. 1997 104:1997;170-193.
32. Schulteis G., Gold L.H., Koob G.F. Preclinical behavioral models for addressing unmet needs in opiate addiction. Sem Neurosci. 9:1997;94-109. a.
33. Schulteis G., Koob G.F. Reinforcement processes in opiate addiction. A homeostatic model Neurochem Res. 21:1996;1437-1454.
34. Schulteis G., Markou A., Gold L.H., Stinus L., Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal. A quantitative dose-response analysis J Pharmacol Exp Ther. 271:1994;1391-1398.
35. Schulteis G., Stinus L., Risbrough V., Weinger M.B., Koob G.F. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal. Soc Neurosci Abstr. 23:1997;528. b.
36. Sparber S.B., Meyer D.R. Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats. Pharmacol Biochem Behav. 9:1978;319-325.
37. Stinus L., Le Moal M., Koob G.F. The nucleus accumbens and amygdala as possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience. 37:1990;767-773.
38. Taylor J.R., Elsworth J.D., Garcia E.J., Grant S.J., Roth R.H., Redmond D.E. Jr. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology. 96:1988;121-124.
39. 2 agonists, rilmenidine and clonidine, on the morphine withdrawal syndrome and their potential addictive properties in rats. Am J Cardiol. 61:1988;35D-38D.
40. Washton A.M., Resnich R.B., Geyer G. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects. J Clin Psychiat. 44:1983;335-337.
41. Wikler A. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment Arch Gen Psychiat. 28:1973;611-616.